Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 5, 2014, Pages

  Walther, Stefanie ^a   Pluteanu, Florentina ^b   Renz, Susanne ^c   Nikonova, Yulia ^b   Maxwell, Joshua T ^a   Yang, Li Zhen ^d,e,k   Schmidt, Kurt ^f   Edwards, Joshua N ^a   Wakula, Paulina ^g   Groschner, Klaus ^g,h   Maier, Lars S ^c,i   Spiess, Joachim ^d,j   Blatter, Lothar A ^a   Pieske, Burkert ^g,h   Kockskämper, Jens ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF GRAZ   (Austria)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

ⁱ UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^j BURNHAM INSTITUTE   (United States)

^k UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

Cardiac myocyte; eNOS phosphorylation; Nitric oxide; Urocortin

Indexed keywords

CARDIAC MYOCYTE; ENOS PHOSPHORYLATION; NITRIC OXIDE; UROCORTIN;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; HEART VENTRICLES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SERINE; SIGNAL TRANSDUCTION; UROCORTINS;

EID: 84906899962     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00694.2013     Document Type: Article

References (46)

1. Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci USA 101: 3697-3702, 2004.
2. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjos OD, Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145: 24-35; discussion 21-23, 2004.
3. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275: 8508-8514, 2000.
4. Brar BK, Stephanou A, Knight R, Latchman DS. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 34: 483-492, 2002.
5. Calderon-Sanchez E, Delgado C, Ruiz-Hurtado G, Dominguez-Rodriguez A, Cachofeiro V, Rodriguez-Moyano M, Gomez AM, Ordonez A, Smani T. Urocortin induces positive inotropic effect in rat heart. Cardiovasc Res 83: 717-725, 2009.
6. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335: 1-13, 1998.
7. Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT, Richards M. Urocortin 2 infusion in human heart failure. Eur Heart J 28: 2589-2597, 2007.
8. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 399: 601-605, 1999.
9. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
10. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 28: 1-27, 2007.
11. Fischmeister R, Castro L, Abi-Gerges A, Rochais F, Vandecasteele G. Species-and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp Biochem Physiol A Mol Integr Physiol 142: 136-143, 2005.
12. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
13. Grossini E, Molinari C, Mary DA, Marino P, Vacca G. The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent. Eur J Pharmacol 578: 242-248, 2008.
14. 2+ related pathways in endothelial cells. Cell Physiol Biochem 23: 87-96, 2009.
15. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35: 719-729, 2003.
16. Huang M, Kempuraj D, Papadopoulou N, Kourelis T, Donelan J, Manola A, Theoharides TC. Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation. J Mol Endocrinol 42: 397-405, 2009.
17. + channels. Br J Pharmacol 135: 1467-1476, 2002.
18. Ikeda K, Tojo K, Otsubo C, Udagawa T, Hosoya T, Tajima N, Nakao K, Kawamura M. Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes. Peptides 26: 2473-2481, 2005.
19. Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K. Urocortin, a newly identified corticotropinreleasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250: 298-304, 1998.
20. Jo SH, Leblais V, Wang PH, Crow MT, Xiao RP. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ Res 91: 46-53, 2002.
21. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87: 340-346, 2002.
22. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, Fischmeister R. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95: 794-802, 1995.
23. 2+ stores. J Cell Sci 121: 186-195, 2008.
24. Kockskamper J, Sheehan KA, Bare DJ, Lipsius SL, Mignery GA, Blatter LA. Activation and propagation of Ca(2+) release during excitation-contraction coupling in atrial myocytes. Biophys J 81: 2590-2605, 2001.
25. Kojda G, Kottenberg K, Nix P, Schluter KD, Piper HM, Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101, 1996.
26. 2+ influx in cardiomyocytes. Circ Res 95: 1183-1190, 2004.
27. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93: 388-398, 2003.
28. Morisco C, Condorelli G, Trimarco V, Bellis A, Marrone C, Sadoshima J, Trimarco B. Akt mediates the cross-talk between betaadrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96: 180-188, 2005.
29. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279, 2007.
30. Movsesian MA, Komas N, Krall J, Manganiello VC. Expression and activity of low Km, cGMP-inhibited cAMP phosphodiesterase in cardiac and skeletal muscle. Biochem Biophys Res Commun 225: 1058-1062, 1996.
31. Rademaker MT, Cameron VA, Charles CJ, Richards AM. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112: 3624-3632, 2005.
32. Satoh H, Delbridge LM, Blatter LA, Bers DM. Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J 70: 1494-1504, 1996.
33. Schillinger W, Teucher N, Sossalla S, Kettlewell S, Werner C, Raddatz D, Elgner A, Tenderich G, Pieske B, Ramadori G, Schondube FA, Kogler H, Kockskamper J, Maier LS, Schworer H, Smith GL, Hasenfuss G. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation 116: 57-66, 2007.
34. Schmidt K, Baer HP. Purification of radioiodinated succinyl cyclic nucleotide tyrosine methyl esters by anion-exchange thin-layer chromatography. Anal Biochem 141: 499-502, 1984.
35. Schmidt K, Mayer B, Kukovetz WR. Effect of calcium on endotheliumderived relaxing factor formation and cGMP levels in endothelial cells. Eur J Pharmacol 170: 157-166, 1989.
36. Smani T, Calderon-Sanchez E, Gomez-Hurtado N, Fernandez-Velasco M, Cachofeiro V, Lahera V, Ordonez A, Delgado C. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes. Cardiovasc Res 87: 459-466, 2010.
37. Terui K, Higashiyama A, Horiba N, Furukawa KI, Motomura S, Suda T. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 169: 177-183, 2001.
38. Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes. J Physiol 533: 329-340, 2001.
39. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576, 2000.
40. Walther S, Awad S, Lonchyna VA, Blatter LA. NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure. Am J Physiol Heart Circ Physiol 306: H856-H866, 2014.
41. Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 143: 508-514, 2004.
42. Yang LZ, Kockskamper J, Heinzel FR, Hauber M, Walther S, Spiess J, Pieske B. Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A. Cardiovasc Res 69: 402-411, 2006.
43. Yang LZ, Kockskamper J, Khan S, Suarez J, Walther S, Doleschal B, Unterer G, Khafaga M, Machler H, Heinzel FR, Dillmann WH, Pieske B, Spiess J. cAMP-and Ca(2+)/calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol 162: 544-556, 2011.
44. Yang LZ, Tovote P, Rayner M, Kockskamper J, Pieske B, Spiess J. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmacol 632: 1-6, 2010.
45. i and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy. Am J Physiol Regul Integr Comp Physiol 288: R140-R148, 2005.
46. Zhang XP, Hintze TH. cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am J Physiol Heart Circ Physiol 290: H2376-H2384, 2006.